BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 22353526)

  • 21. Norepinephrine stimulates pancreatic cancer cell proliferation, migration and invasion via β-adrenergic receptor-dependent activation of P38/MAPK pathway.
    Huang XY; Wang HC; Yuan Z; Huang J; Zheng Q
    Hepatogastroenterology; 2012 May; 59(115):889-93. PubMed ID: 22020907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of pancreatic cancer cell proliferation by propranolol occurs through apoptosis induction: the study of beta-adrenoceptor antagonist's anticancer effect in pancreatic cancer cell.
    Zhang D; Ma Q; Shen S; Hu H
    Pancreas; 2009 Jan; 38(1):94-100. PubMed ID: 19106745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epinephrine stimulates esophageal squamous-cell carcinoma cell proliferation via beta-adrenoceptor-dependent transactivation of extracellular signal-regulated kinase/cyclooxygenase-2 pathway.
    Liu X; Wu WK; Yu L; Sung JJ; Srivastava G; Zhang ST; Cho CH
    J Cell Biochem; 2008 Sep; 105(1):53-60. PubMed ID: 18452159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antitumor activity of TGF-beta inhibitor is dependent on the microenvironment.
    Medicherla S; Li L; Ma JY; Kapoun AM; Gaspar NJ; Liu YW; Mangadu R; O'Young G; Protter AA; Schreiner GF; Wong DH; Higgins LS
    Anticancer Res; 2007; 27(6B):4149-57. PubMed ID: 18229422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of transforming growth factor beta signaling reduces pancreatic adenocarcinoma growth and invasiveness.
    Gaspar NJ; Li L; Kapoun AM; Medicherla S; Reddy M; Li G; O'Young G; Quon D; Henson M; Damm DL; Muiru GT; Murphy A; Higgins LS; Chakravarty S; Wong DH
    Mol Pharmacol; 2007 Jul; 72(1):152-61. PubMed ID: 17400764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Stress and pancreatic carcinoma--β-adrenergic signaling and tumor biology].
    Hefner J; Csef H; Kunzmann V
    Dtsch Med Wochenschr; 2014 Feb; 139(7):334-8. PubMed ID: 24496896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. β-Adrenergic modulation of cancer cell proliferation: available evidence and clinical perspectives.
    Coelho M; Soares-Silva C; Brandão D; Marino F; Cosentino M; Ribeiro L
    J Cancer Res Clin Oncol; 2017 Feb; 143(2):275-291. PubMed ID: 27709364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of adrenergic signaling in breast cancer biology.
    Obeid EI; Conzen SD
    Cancer Biomark; 2013; 13(3):161-9. PubMed ID: 23912488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. β3-Adrenoceptor, a novel player in the round-trip from neonatal diseases to cancer: Suggestive clues from embryo.
    Filippi L; Pini A; Cammalleri M; Bagnoli P; Dal Monte M
    Med Res Rev; 2022 May; 42(3):1179-1201. PubMed ID: 34967048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The neuroendocrine impact of chronic stress on cancer.
    Thaker PH; Lutgendorf SK; Sood AK
    Cell Cycle; 2007 Feb; 6(4):430-3. PubMed ID: 17312398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. β-Adrenergic Signaling in Lung Cancer: A Potential Role for Beta-Blockers.
    Nilsson MB; Le X; Heymach JV
    J Neuroimmune Pharmacol; 2020 Mar; 15(1):27-36. PubMed ID: 31828732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ligand-directed signalling at beta-adrenoceptors.
    Evans BA; Sato M; Sarwar M; Hutchinson DS; Summers RJ
    Br J Pharmacol; 2010 Mar; 159(5):1022-38. PubMed ID: 20132209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of adrenergic signaling in skin cancer progression: possible repurposing of β-blockers for treatment of skin cancer.
    Yang EV; Eubank TD
    Cancer Biomark; 2013; 13(3):155-60. PubMed ID: 23912487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of tobacco constituents and psychological stress on the beta-adrenergic regulation of non-small cell lung cancer and pancreatic cancer: implications for intervention.
    Schuller HM
    Cancer Biomark; 2013; 13(3):133-44. PubMed ID: 23912485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ß-Adrenoreceptors in Human Cancers.
    Kraboth Z; Kalman B
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism and Effect of Beta-Blockers on Pancreatic Adenocarcinoma: A Literature Review.
    Upadhyaya VD; Douedi S; Garcia B; Gonzalez J; Udongwo N; Wei J; Nai Q; Asif A; Sen S
    J Clin Med Res; 2020 Dec; 12(12):753-757. PubMed ID: 33447308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beta-adrenoceptor action on pancreatic cancer cell proliferation and tumor growth in mice.
    Lin X; Luo K; Lv Z; Huang J
    Hepatogastroenterology; 2012; 59(114):584-8. PubMed ID: 22353526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intercepting neoplastic progression in lung malignancies via the beta adrenergic (β-AR) pathway: implications for anti-cancer drug targets.
    Al-Wadei HA; Ullah MF; Al-Wadei MH
    Pharmacol Res; 2012 Jul; 66(1):33-40. PubMed ID: 22487140
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.